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Comprehensive human ureter proteome dataset was generated
from OFFGel fractionated ureter samples. Our result showed that
among 2217 non-redundant ureter proteins, 751 protein candi-
dates (33.8%) were detected in urine as urinary protein/polypep-
tide or exosomal protein. On the other hand, comparing ureter
protein hits (48) that are not shown in corresponding databases to
urinary bladder and prostate human protein atlas databases pin-
pointed 21 proteins that might be unique to ureter tissue. In
conclusion, this ﬁnding offers future perspectives for possible
identiﬁcation of ureter disease-associated biomarkers such as
ureter carcinoma. In addition, Cytoscape GO annotation was
examined on the ﬁnal ureter dataset to better understand proteins
molecular function, biological processes, and cellular component.
The ureter proteomic dataset published in this article will provide
a valuable resource for researchers working in the ﬁeld of urology
and urine biomarker discovery.
& 2016 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).vier Inc. This is an open access article under the CC BY license
ehmagd@med.niigata-u.ac.jp (S. Magdeldin).
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Dataset presented in this article summarize the human ureter proteome. Whole tissue protein was
extracted from healthy ureters and subjected to OFFGel prefractionation [1–5] to simplify sample
complexity. The use of OFFGel prefractionation enabled deep proteome mapping of conﬁdent pro-
teins. Next, generated ureter proteome was compared qualitatively to other databases to generate
protein candidates associated with ureter tissue.2. Experimental design, materials and methods
Normal healthy ureter biopsy sample (4–5 cm length) was obtained from individuals with
informed consent and under the approval of Committee of Ethics for Life and Genes of the Graduate
School of Medical and Dental Sciences, Niigata University. Protein extracts were obtained by placing
dissected ureter tissues in protein OFFGel prefractionation buffer supplied by the manufacturer
(containing urea, thiourea, DTT, glycerol, and buffer with ampholytes pH (3–10)). Complete ultra-
proteases (Roche, Mannheim) was added to the buffer. Precellys 24 tissue homogenizer was used for
protein extraction at 4 °C. (Precellys, Bertin technologies). 2 mg of recovered protein extract was
subjected to OFFGel prefractionation as previously described [6]. Following successful prefractiona-
tion, acetone precipitation, and protein quantiﬁcation, 80 mg from each OFFGel fractions (n¼12) were
subjected to reduction and alkylation, and digested with trypsin as described elsewhere [7,8].
Digested peptide solution was acidiﬁed using 90% formic acid to a ﬁnal pH 3 and enriched using stage
tip15, 16. Efﬁciency of fractionation and digestion was conﬁrmed as shown in Fig. 1. Chromatography
of puriﬁed peptides was performed using Thermo Q-Exactive and separation was applied using a
binary gradient for 120 min with acetonitrile as mobile phase. The precursor full MS scan ranged from
40 to 1200 m/z. Dynamic exclusion setting used were as follows: repeat count, 1; repeat duration,
Fig. 1. Clockwise from top left: silver stained SDS-PAGE of protein OffGel fractionation, stained with Commassie brilliant blue
(R-250), silver stained SDS-PAGE of tryptic peptides, stained with Commassie brilliant blue (R-250).
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Peptide Atlas repository at ftp://PASS00641:ZI6249ae@ftp.peptideatlas.org/.
Protein and peptide identiﬁcation were searched by MASCOT in addition to ProluCID search engine
implemented in the integrated proteomics pipeline; IP2 (http://integratedproteomics.com/, version
1.01). Tandem mass spectra were generated using RawExtract (Ver 1.9.9) and the MS/MS spectra were
searched against updated UniProtKB/TrEMBL (Homo sapiens, 935,651 entries). The spectral search
space included all fully and half tryptic peptide candidates within a 50-ppm window surrounding the
peptide candidate precursor mass. Carbamidomethylation (þ57.02146) of cysteine was considered a
static modiﬁcation and oxidation at M, HW (þ15.995) as variable modiﬁcation. Peptide candidates
were ﬁltered to 0.1% FDR and proteins candidates to 1% FDR using DTASelect with a 10-ppm
(Figs. 3 and 4).Conﬂicts of interest
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Fig. 2. Identiﬁed proteins and peptides of the human ureter proteome. Upper ﬁgure, identiﬁed non-redundant proteins (within
fraction) in 12 OffGel fractions. Lower, identiﬁed non-redundant peptides (within fraction) in 12 OffGel fractions. Black bars
represent unique protein or peptide candidate within fraction. Gray bars represent newly added proteins/peptides from the
subsequent fraction.
Fig. 3. Venn diagrams of unique and shared ureter proteome with other databases. (A) Venn diagram of human ureter pro-
teome overlapped with urinary, urinary exosomal, and kidney mass spectrometric databases. (B) Non-shared proteins in panel
A (zone A) was further compared to human urinary bladder and prostate databases retrieved from human protein atlas (based
on immunohistochemistry) where 27 proteins were shared and 21.
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Fig. 4. Whisker and box plot overlaid with dot plot showing median and quartile values of the Modiﬁed Protein Abundance
(emPAI) for ureter proteome database. Color dots represent pie zone location based on Fig. 2A sorting. Y axis shows emPAI
value in log2 view.
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Supplementary data associated with this article can be found in the online version at http://dx.doi.
org/10.1016/j.dib.2016.01.050.References
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